Document:

EX-10.1

FIRST AMENDMENT

THIS FIRST AMENDMENT (this “Amendment”) dated as of February 28, 2013 to the Loan
Agreement referenced below is between Vocus, Inc., a Delaware corporation (the “Borrower”),
the Guarantors identified on the signature pages hereto and Bank of America, N.A. (the
“Bank”).

W I T N E S S E T H

WHEREAS, pursuant to the Loan Agreement (as amended, modified and supplemented from time to
time, the “Loan Agreement”) dated as of February 27, 2012 among the Borrower and the Bank,
the Bank has agreed to make credit extensions available to the Borrower; and

WHEREAS, the Borrower has requested an amendment to the Loan Agreement and the Bank has agreed
to the requested amendment on the terms and conditions set forth herein.

NOW, THEREFORE, IN CONSIDERATION of the premises and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound
hereby, the parties hereto agree as follows:

1. Defined Terms. Capitalized terms used herein but not otherwise defined herein
shall have the meanings provided to such terms in the Loan Agreement.

2. Amendments.

	 	2.1	 	In Section 2.2(a) of the Loan Agreement the reference to “February 27, 2013” is
amended to read “April 15, 2014”.

	 	2.2	 	In Section 7.2(b) of the Loan Agreement the phrase “(including the last fiscal
quarter in each fiscal year)” is amended to read “(other than the last fiscal quarter
in each fiscal year)”.

3. Conditions Precedent. This Amendment shall be effective as of the date hereof upon
satisfaction of the following conditions precedent in each case in form and substance acceptable to
the Bank:

(a) Receipt by the Bank of executed copies of this Amendment by the Loan Parties.

(b) Receipt by the Bank of an opinion of legal counsel to the Loan Parties.

(c) Receipt by the Bank of resolutions adopted by the board of directors (or equivalent
governing body) of each Loan Party approving this Amendment and the transactions
contemplated hereby, in each case certified by a secretary or assistant secretary of such
Loan Party, as applicable, to be true and correct as of the date hereof and in each case in
form and substance reasonably satisfactory to the Bank.

(d) Receipt by the Bank of a renewal fee in an amount equal to $37,500.00.

4. Amendment is a “Loan Document”. This Amendment is a Loan Document and all
references to a “Loan Document” in the Loan Agreement and the other Loan Documents (including,
without limitation, all such references in the representations and warranties in the Loan Agreement
and the other Loan Documents) shall be deemed to include this Amendment.

5. Reaffirmation of Representations and Warranties; No Default. The Borrower
represents and warrants to the Bank that after giving effect to this Amendment, (a) the
representations and warranties of the Loan Parties contained in the Loan Documents, or which are
contained in any document furnished at any time under or in connection therewith, are true and
correct in all material respects on and as of the date hereof and (b) no Event of Default under the
Loan Agreement, or any event which, with notice or lapse of time would constitute an Event of
Default under the Loan Agreement, exists as of the date hereof.

6. Reaffirmation of Obligations. Each Loan Party (a) acknowledges and consents to all
of the terms and conditions of this Amendment, (b) affirms all of its obligations under the Loan
Documents and (c) agrees that this Amendment and all documents, agreements and instruments executed
in connection with this Amendment do not operate to reduce or discharge such Loan Party’s
obligations under the Loan Documents

7. Reaffirmation of Security Interests. Each Loan Party (a) affirms that each of the
Liens granted in or pursuant to the Loan Documents are valid and subsisting and (b) agrees that
this Amendment shall in no manner impair or otherwise adversely affect any of the Liens granted in
or pursuant to the Loan Documents.

8. No Other Changes. Except as modified hereby, all of the terms and provisions of
the Loan Documents shall remain in full force and effect.

9. Counterparts; Delivery. This Amendment may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed an original and it shall
not be necessary in making proof of this Amendment to produce or account for more than one such
counterpart. Delivery of an executed counterpart of this Amendment by facsimile or other electronic
imaging means shall be effective as an original.

10. Governing Law. This Amendment is governed by and shall be interpreted according
to federal law and the laws of New York.

[SIGNATURE PAGES FOLLOW]

1

IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Amendment to be
duly executed and delivered as of the date first above written.

	 	 	 	 	 
	BORROWER:
	 	VOCUS, INC., a Delaware corporation

	 	

	 	 	By: /s/ Stephen A. Vintz (Seal)

	 	

	 	 	 

	 	

	 	 	Name:Stephen A. Vintz

Title:Executive Vice President and Chief Financial Officer

	 	

	GUARANTORS:
	 	VOCUS ACQUISITION LLC,

a Maryland limited liability company

VOCUS PRW HOLDINGS LLC,

a Maryland limited liability company

VOCUS NM LLC, a Maryland limited liability company

VOCUS SOCIAL MEDIA LLC,

a California limited liability company

ICONTACT LLC, a Delaware limited liability company

	 	

	 	 	By:VOCUS, INC., a Delaware corporation,

As sole member of each of the foregoing

	 	

	 	 	By:/s/ Stephen A. Vintz

	 	(Seal)
	 	 	 

	 	

	 	 	Name:Stephen A. Vintz

Title:Executive Vice President and

Chief Financial Officer

	 	

	BANK:
	 	BANK OF AMERICA, N.A.

	 	

	 	 	 	 	 
	 	 

                   By:      }   /s/ Michael J. Radcliffe

                   Name:   Michael J. Radcliffe
                   Title:       Senior Vice President
By:
    	 	 	 	/s/ Michael J. Radcliffe
	 	 	Name:	 	 	 	Michael J. Radcliffe
	 	 	Title:	 	 	 	Senior Vice President

2IMI-ElpidaAgmt-redacted-Ex10.17_SV (1)

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

This First Fee Triggering Technology agreement (the “Agreement”) is entered into and made effective as of the date that this Agreement is signed by the last party to sign below (the “Effective Date”), by and between ELPIDA MEMORY, INC., a Japanese corporation operating at 2-1, Yaesu 2-chome, Chuo-ku, Tokyo 104-0028, Japan (“Elpida”), and INTERMOLECULAR, INC., a Delaware corporation operating at 3011 North First Street, San Jose, California 95134 (“Intermolecular”).  Elpida and Intermolecular may be referred to individually as a “Party,” or collectively as the “Parties.”

WHEREAS, Elpida and Intermolecular have entered into certain advanced memory agreements:  
		
	1.
	Advanced Memory Development Program Agreement, dated May 22, 2008; (“1st Agreement”)

		
	2.
	Exhibit C – Royalty Terms, dated August 18, 2008; (“2nd Agreement”)

		
	3.
	Supplemental Joint Development Agreement, dated January 27, 2009; (“3rd Agreement”)

		
	4.
	Amendment to the Supplemental Joint Development Agreement, dated May 25, 2009; (“4th Agreement”)

		
	5.
	Amendment to the Advanced Memory Agreements, dated July 29, 2010 (“5th Agreement”) 

(collectively, the “Advanced Memory Agreements”);

WHEREAS, Elpida and Intermolecular wish to confirm the amounts and dates for payment of certain royalty payments in accordance with the terms of the 5th Agreement, including without limitation, Sections 2.2 and 2.3 thereof.

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:
		
	1.
	All capitalized terms not defined herein shall have the meaning set forth in the Advanced Memory Agreements. 

		
	2.
	The following CDP Developed Technology constitutes Fee Triggering Technology –

		
	2.1
	[***] (“First Fee Triggering Technology”).

		
	3.
	The following product constitutes a Product – 

		
	3.1
	[***] (“First Product”).

		
	4.
	The First Fee Triggering Technology shall be first utilized in the First Product on January 1, 2013 (“First Fee Trigger Date”) 

		
	5.
	In consideration for utilization of the First Fee Triggering Technology in the First Product, Elpida shall pay Intermolecular [***] US Dollars (US[***]) per year for [***] years (“First Annual Contribution Fee Period”) beginning on the First Fee Trigger Date.

		
	6.
	Elpida shall pay the aforementioned amount during the First Annual Contribution Fee Period in quarterly payments of US$[***] in accordance with the followings: 

		
	6.1
	Elpida shall make a payment of [***] US Dollars (US$[***]) on the first day of the first calendar quarter of 2013, and the following schedule shall govern the remaining payments for each calendar quarter:

		
	A.
	If on or before [***], 2013, Elpida has shipped the First Product for commercial use by Elpida’s customer or Elpida has not shipped the First Product for a reason other than the [***], Elpida shall make a payment of [***] US Dollars (US[***]) on [***], 2013 and a payment of [***] Dollars (US $[***]) on [***], 2013 and on the first day of each calendar quarter through the First Annual Contribution Fee Period;

		
	B.
	If Elpida has not shipped the First Product for commercial use by Elpida’s customer by [***], 2013 due to [***] but shipped it on or before [***], 2013, Elpida shall make a payment of [***] US Dollars (US$[***]) on [***], 2013 as the remaining payment of the first calendar quarter of 2013, a payment of [***] Dollars (US $[***]) on [***], 2013, a payment of [***] Dollars (US $[***]) on [***], 2013, and a payment of [***] Dollars (US $[***]) on the first day of each calendar quarter thereafter, through the First Annual Contribution Fee Period; or

		
	C.
	If Elpida has not shipped the First Product for commercial use by Elpida’s customer by [***], 2013 due to the [***], Elpida shall make a payment of [***] US Dollars (US$[***]) on [***], 2013.  Additionally, the parties will discuss in good faith the timing of the remaining payments of [***] US Dollars (US$[***]) for the first calendar quarter of 2013, the second calendar quarter of 2013 and of the payments for each calendar quarter thereafter through the First Annual Contribution Fee Period.  Nothing in this Section 6.1 (C), is intended to reduce Elpida’s obligations to make a payment of [***] US Dollars (US$[***]) for each calendar quarter under Section 2.2 or a payment of [***] US Dollars (US$[***]) for each calendar quarter during the Annual Contribution Fee Period under Section 2.3 of the 5th Agreement.

		
	6.2
	No Other Modifications. Other than as provided herein, no other amendments are being made to the Advanced Memory Agreements, and all other provisions of the Advanced Memory Agreements shall remain in full force and effect in accordance with the terms of the Advanced Memory Agreements. 

[The remainder of this page is intentionally left blank.]
 
 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

IN WITNESS WHEREOF, the parties hereto have executed this document as the last date set forth below. 

ELPIDA MEMORY, INC.            INTERMOLECULAR, INC.    

By:    /s/ Hideki Gomi________________    By:    /s/ David E. Lazovsky___________    
Name:       Hideki Gomi                                       Name:    David E. Lazovsky    
Title:       Chief Technology Officer                  Title:    President and CEO    
Date:    Dec. 29, 2012     _______________    Date:    December 29, 2012

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]